These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2661066

  • 1. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
    Lee GS, Woo KT, Lim CH.
    Clin Nephrol; 1989 May; 31(5):276. PubMed ID: 2661066
    [No Abstract] [Full Text] [Related]

  • 2. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 3. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
    Brodsky SV, Rovin BH, Hebert LA.
    Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
    [No Abstract] [Full Text] [Related]

  • 4. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
    Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH.
    Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
    [Abstract] [Full Text] [Related]

  • 5. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
    Woo KT, Lee GS, Pall AA.
    Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 7. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 8. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
    Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
    [Abstract] [Full Text] [Related]

  • 9. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
    Woo KT, Chiang GS, Lim CH.
    Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
    [No Abstract] [Full Text] [Related]

  • 10. IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
    Woo KT, Chiang GS, Lau YK, Lim CH.
    Semin Nephrol; 1987 Dec; 7(4):379-81. PubMed ID: 3445021
    [No Abstract] [Full Text] [Related]

  • 11. Clinical effect of dipyridamole in patients with IgA nephropathy.
    Yagame M, Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
    [Abstract] [Full Text] [Related]

  • 12. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
    Yoshikawa N, Ito H.
    Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [Abstract] [Full Text] [Related]

  • 14. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
    Chan MK, Kwan SY, Chan KW, Yeung CK.
    Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
    [Abstract] [Full Text] [Related]

  • 15. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
    Woo KT, Chiang GS, Yap HK, Lim CH.
    Ann Acad Med Singap; 1988 Apr; 17(2):226-31. PubMed ID: 3408224
    [Abstract] [Full Text] [Related]

  • 16. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
    Ciavarella N, Antoncecchi S, D'Elia N.
    Cardiologia; 1985 Apr; 30(4):301-7. PubMed ID: 3914360
    [No Abstract] [Full Text] [Related]

  • 17. [Rheological and blood coagulation control during treatment of diffuse kidney diseases].
    Zhavoronkov EK, Potapov VV, Potapova IV.
    Klin Med (Mosk); 1981 Jan; 59(1):57-63. PubMed ID: 7017262
    [No Abstract] [Full Text] [Related]

  • 18. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
    Shearman JD, Yin ZG, Aarons I, Smith PS, Woodroffe AJ, Clarkson AR.
    Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
    [Abstract] [Full Text] [Related]

  • 19. The treatment of glomerulonephritis.
    Kincaid-Smith P.
    Aust N Z J Med; 1980 Jun; 10(3):340-5. PubMed ID: 6931575
    [No Abstract] [Full Text] [Related]

  • 20. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U.
    Am J Med; 1983 Dec; 75(6):920-7. PubMed ID: 6359877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.